EcoR1 Capital
Overview
EcoR1 Capital, LLC is a biotech focused investment advisory firm.
Investment Focus
- Qualified purchasers for Venture Funds and SPVs
Portfolio Companies
Get the full list of 54,000+ investors
EcoR1 Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about EcoR1 Capital
What sectors does EcoR1 Capital invest in?
EcoR1 Capital invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in San Francisco, California, United States. EcoR1 Capital is listed as a private investment firm in the ConnectSafely investor database.
What stage does EcoR1 Capital invest at?
EcoR1 Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 50M - 150M.
Which regions does EcoR1 Capital invest in?
EcoR1 Capital invests across United States.
Who are the partners at EcoR1 Capital?
Team members listed for EcoR1 Capital include Sarah Marriott (Chief Operating Officer) and Caroline Stout (Partner).
What companies has EcoR1 Capital invested in?
EcoR1 Capital's portfolio includes ReCode Therapeutics, Attovia Therapeutics and Scorpion Therapeutics.
How do I contact EcoR1 Capital?
EcoR1 Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
